NASDAQ:OMIC Singular Genomics Systems (OMIC) Stock Price, News & Analysis $5.89 -0.29 (-4.69%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$5.55▼$6.1850-Day Range$5.89▼$8.7452-Week Range$5.55▼$19.80Volume21,910 shsAverage Volume5,156 shsMarket Capitalization$14.54 millionP/E RatioN/ADividend YieldN/APrice Target$10.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Singular Genomics Systems alerts: Email Address Singular Genomics Systems MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside82.4% Upside$10.75 Price TargetShort InterestHealthy0.94% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.59 out of 5 starsMedical Sector380th out of 910 stocksAnalytical Instruments Industry13th out of 26 stocks 3.0 Analyst's Opinion Consensus RatingSingular Genomics Systems has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageSingular Genomics Systems has only been the subject of 1 research reports in the past 90 days.Read more about Singular Genomics Systems' stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted0.94% of the float of Singular Genomics Systems has been sold short.Short Interest Ratio / Days to CoverSingular Genomics Systems has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Singular Genomics Systems has recently decreased by 0.71%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldSingular Genomics Systems does not currently pay a dividend.Dividend GrowthSingular Genomics Systems does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OMIC. Previous Next 2.0 News and Social Media Coverage News SentimentSingular Genomics Systems has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Singular Genomics Systems this week, compared to 1 article on an average week. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Singular Genomics Systems insiders have not sold or bought any company stock.Percentage Held by Insiders22.20% of the stock of Singular Genomics Systems is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions65.80% of the stock of Singular Genomics Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Singular Genomics Systems' insider trading history. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Singular Genomics Systems is -0.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Singular Genomics Systems is -0.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSingular Genomics Systems has a P/B Ratio of 0.08. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Singular Genomics Systems' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About Singular Genomics Systems Stock (NASDAQ:OMIC)Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.Read More OMIC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OMIC Stock News HeadlinesSeptember 6 at 1:50 AM | americanbankingnews.comSingular Genomics Systems (NASDAQ:OMIC) Shares Up 0.3%August 16, 2024 | msn.comQuantum leap in single cell genomics: Scale Bio launches groundbreaking ‘100 Million Cell Challenge’ in collaboration with Ultima Genomics and NVIDIASeptember 7, 2024 | Porter & Company (Ad)War on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.August 14, 2024 | msn.comIndia's Ola Electric posts bigger Q1 lossAugust 14, 2024 | finance.yahoo.comQ2 2024 Singular Genomics Systems Inc Earnings CallAugust 14, 2024 | seekingalpha.comSingular Genomics Systems, Inc. (OMIC) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | markets.businessinsider.comSingular Genomics Reports Recent Highlights and Second Quarter 2024 Financial ResultsAugust 12, 2024 | markets.businessinsider.comWhat Wall Street expects from Singular Genomics Systems's earningsSeptember 7, 2024 | Porter & Company (Ad)War on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.July 30, 2024 | globenewswire.comSingular Genomics to Report Second Quarter 2024 Financial Results on August 13, 2024July 15, 2024 | globenewswire.comSingular Genomics Regains Compliance with Nasdaq Minimum Bid Price RequirementJune 26, 2024 | investorplace.comOMIC Stock Earnings: Singular Genomics Sys Beats EPS, Misses Revenue for Q2 2023June 24, 2024 | benzinga.comEnerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On MondayJune 21, 2024 | globenewswire.comSingular Genomics Announces 1-for-30 Reverse Stock SplitMay 29, 2024 | globenewswire.comSingular Genomics to Present at the Goldman Sachs Global Healthcare ConferenceMay 16, 2024 | insidermonkey.comSingular Genomics Systems, Inc. (NASDAQ:OMIC) Q1 2024 Earnings Call TranscriptMay 15, 2024 | finance.yahoo.comQ1 2024 Singular Genomics Systems Inc Earnings CallMay 15, 2024 | finance.yahoo.comSingular Genomics Systems Inc (OMIC) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...See More Headlines Receive OMIC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/13/2024Today9/07/2024Next Earnings (Estimated)11/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Analytical instruments Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:OMIC CUSIPN/A CIK1850906 Websingulargenomics.com Phone858-333-7830FaxN/AEmployees220Year FoundedN/APrice Target and Rating Average Stock Price Target$10.75 High Stock Price Target$15.00 Low Stock Price Target$6.50 Potential Upside/Downside+82.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($39.64) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-94,820,000.00 Net Margins-3,375.72% Pretax Margin-3,375.72% Return on Equity-54.66% Return on Assets-36.42% Debt Debt-to-Equity Ratio0.05 Current Ratio8.77 Quick Ratio8.04 Sales & Book Value Annual Sales$2.72 million Price / Sales5.34 Cash FlowN/A Price / Cash FlowN/A Book Value$73.25 per share Price / Book0.08Miscellaneous Outstanding Shares2,467,000Free Float1,919,000Market Cap$14.54 million OptionableOptionable Beta1.34 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Andrew Spaventa (Age 39)Founder, CEO, President & Chairperson of the Board Comp: $685.93kDr. David L. Barker Ph.D. (Age 82)Founder, Member of Scientific Advisory Board & Independent Director Comp: $63.75kDr. Eli N. Glezer Ph.D. (Age 55)Founder, Chief Scientific Officer & Chair of Scientific Advisory Board Comp: $496.5kMr. Dalen Meeter (Age 46)Chief Financial Officer Comp: $434.39kJyotsna GhaiChief Operating OfficerMr. Jorge Velarde Jr. (Age 57)MBA, Senior Vice President of Corporate Development & Strategy Mr. Jeff BullardHead of SalesMr. Vincent Brancaccio (Age 41)Head of Human Resources Mr. Samuel Ropp Ph.D. (Age 50)Chief Commercial Officer More ExecutivesKey CompetitorsCara TherapeuticsNASDAQ:CARAOptex SystemsNASDAQ:OPXSSyntec OpticsNASDAQ:OPTXPrenetics GlobalNASDAQ:PREAccelerate DiagnosticsNASDAQ:AXDXView All CompetitorsInsiders & InstitutionsPerceptive Advisors LLCSold 2,055,997 shares on 8/16/2024Ownership: 2.874%Deerfield Management Company L.P. Series CSold 4,818,709 shares on 8/15/2024Ownership: 6.735%ARCH Venture Management LLCSold 3,672,296 shares on 8/14/2024Ownership: 5.133%QVIDTVM Management LLCSold 2,423,137 shares on 8/14/2024Ownership: 3.387%Eli N GlezerBought 6,666 shares on 11/16/2023Total: $85,991.40 ($12.90/share)View All Insider TransactionsView All Institutional Transactions OMIC Stock Analysis - Frequently Asked Questions How have OMIC shares performed this year? Singular Genomics Systems' stock was trading at $13.8030 on January 1st, 2024. Since then, OMIC shares have decreased by 57.3% and is now trading at $5.8923. View the best growth stocks for 2024 here. How were Singular Genomics Systems' earnings last quarter? Singular Genomics Systems, Inc. (NASDAQ:OMIC) released its earnings results on Tuesday, August, 13th. The company reported ($8.57) earnings per share (EPS) for the quarter, beating the consensus estimate of ($8.86) by $0.29. The firm had revenue of $0.74 million for the quarter, compared to analyst estimates of $0.40 million. Singular Genomics Systems had a negative trailing twelve-month return on equity of 54.66% and a negative net margin of 3,375.72%. When did Singular Genomics Systems' stock split? Singular Genomics Systems's stock reverse split before market open on Wednesday, June 26th 2024. The 1-30 reverse split was announced on Wednesday, June 26th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 26th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. When did Singular Genomics Systems IPO? Singular Genomics Systems (OMIC) raised $178 million in an initial public offering (IPO) on Thursday, May 27th 2021. The company issued 8,500,000 shares at a price of $20.00-$22.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank served as the underwriters for the IPO. Who are Singular Genomics Systems' major shareholders? Singular Genomics Systems' top institutional investors include Deerfield Management Company L.P. Series C (6.74%), ARCH Venture Management LLC (5.13%), QVIDTVM Management LLC (3.39%) and Perceptive Advisors LLC (2.87%). Insiders that own company stock include Eli N Glezer, Andrew Spaventa and Michael J Pellini. View institutional ownership trends. How do I buy shares of Singular Genomics Systems? Shares of OMIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:OMIC) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Singular Genomics Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Singular Genomics Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OMIC Stock Alerts